Hypertension Trial, Recruiting NCT06962488 Sponsor: University of Alabama at Birmingham Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06962488
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 55 years at the time of screening.
  • People who have been diagnosed with high blood pressure, shown by a resting blood pressure reading of 130–160 (top number) or 80–100 (bottom number) measured in a clinic, or who are currently taking medication for high blood pressure.
  • People whose overall heart health score is considered poor, based on a standardised scoring tool called Life's Essential 8, with a score below 50.
  • People who are willing and able to wear a blood pressure monitor for 24 hours to confirm their high blood pressure diagnosis.
  • People who are able to give their informed consent to take part.

Who may not be able to join:

  • People with a history of heart or blood vessel disease, including heart attack, chest pain (angina), irregular heartbeat, coronary heart disease, heart failure, stroke, or a mini-stroke (transient ischemic attack).
  • People whose body weight falls outside a certain range — specifically, those with a BMI below 18.5 or above 45 (confirm with trial site for exact calculation).
  • People whose resting clinic blood pressure reading is above 160 (top number) or above 100 (bottom number).
  • People who are currently taking more than two different types of blood pressure medication.
  • People whose 24-hour blood pressure monitoring results do not confirm high blood pressure according to the standard diagnostic guidelines used by the trial.
  • People who are pregnant or breastfeeding.
  • People whose kidneys are not filtering blood well enough, based on a specific blood test result (confirm with trial site).
  • People whose urine test shows a certain level of a protein called albumin, which can indicate kidney stress (confirm with trial site).
  • People whose liver enzyme levels are more than three times higher than the normal range, based on a blood test.
  • People with significant mental health conditions, assessed using a standardised questionnaire called the General Health Questionnaire-12.
  • People with moderate or severe anxiety, based on a score above 16 on a standardised anxiety questionnaire called the Beck Anxiety Inventory.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pankaj Arora, MD, FAHA, University of Alabama at Birmingham

Phone: 2059347173

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
31 March 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Mean 24-Hour Systolic Blood Pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov